Results 161 to 170 of about 138,421 (254)
Delayed drug hypersensitivity to anti-tuberculosis drug: a new desensitization scheme. [PDF]
Bulut İ +4 more
europepmc +1 more source
Abstract Background This randomized controlled trial aims to evaluate alveolar ridge preservation (ARP) with or without a biologically active amnion–chorion membrane (BACM). Methods Thirty patients requiring tooth extraction in the esthetic zone were randomly assigned to 2 groups.
Magdalena Orlowska +8 more
wiley +1 more source
Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis. [PDF]
Pallardy M +13 more
europepmc +1 more source
Abstract Ustekinumab (UST) is a monoclonal antibody used in the management of moderate to severe inflammatory bowel disease. While generally well‐tolerated, serious adverse reactions, including hypersensitivity and anaphylaxis, have been documented, specifical following the initial intravenous (IV) dose.
Kennedy Sparling +2 more
wiley +1 more source
Editorial: Biomarkers in Drug Hypersensitivity
José A. G. Agúndez +4 more
doaj +1 more source
Aspirin and nonsteroidal anti-inflammatory drug hypersensitivity evaluations in pregnancy: A case series of initiating low-dose aspirin. [PDF]
Tsao LR +4 more
europepmc +1 more source
Abstract Objectives Eosinophilic esophagitis (EoE) is a type 2 cytokine‐mediated chronic inflammatory condition leading to esophageal dysfunction. Dupilumab blocks IL‐4 and IL‐13 signaling, which are key inflammatory mediators in EoE and other allergic disorders.
Sindhura Kasturi +6 more
wiley +1 more source
Drug Rash With Eosinophilia and Systemic Symptoms (DRESS) Due to Multiple Anti-Epileptic Drug Hypersensitivity. [PDF]
Ajon ARS, Camara PTA.
europepmc +1 more source
Abstract Skin and lung findings, including the rare findings of leukocytoclastic vasculitis (LCV) and necrobiotic pulmonary nodules, are known extraintestinal manifestations (EIMs) of inflammatory bowel disease. However, these rare EIMs have typically been reported as being a sign of active intestinal disease.
Joshua D. Noe +3 more
wiley +1 more source

